Erratum to “2019 ESC/EAS Guidelines for the Management of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk” [Atherosclerosis 290 (2019) 140–205]

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2019.11.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

ESC/EAS Guidelines for the Management of Dyslipidaemias

Atherosclerosis
Cardiovascular MedicineCardiology
2011English

ESC/EAS Guidelines for the Management of Dyslipidaemias

Revista española de cardiología (English ed.)
Medicine
2011English

2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy

Kardiologia Polska
Cardiovascular MedicineCardiology
2019English

Pharmacotherapy of Pulmonary Hypertension (According to the 2015 ESC/EAS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension)

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2016English

Revised Guidelines for Cardiovascular Risk Management

British Journal of General Practice
MedicineFamily Practice
2011English

2019 Guidelines for the Management of Hypertension — Part 1–7

Arterial Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Guidelines to the Practice of Anesthesia – Revised Edition 2019

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2018English

The ESC 2019 CCS Guidelines: Have We Left Our Patients and Scientific Evidence Behind?

European Journal of Internal Medicine
Internal Medicine
2020English

Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy